Acetylsalicylic-acid-containing drugs and nonsteroidal anti-inflammatory drugs available in Canada

CMAJ. Canadian Medical Association Journal

Volumn 156, Issue 7, 1997, Pages 1025-1028

  Brigden, Malcolm ^a   Smith, Reginald E ^b  

^a Penticton Regional Hospital   (Canada)

^b ROYAL JUBILEE HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CANADA; DRUG MECHANISM; PRESCRIPTION;

EID: 0030994818     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Rubin RJ, Brown DJ, Taylor JW. Public awareness of aspirin and sources of aspirin information in a rural Iowa community. J Community Health 1983; 8:229-39.
2. Rubin RJ, Brown DJ, Taylor JW. Public awareness of aspirin and sources of aspirin information in a rural Iowa community. J Community Health 1983;8:229-39.
3. National Center for Health Statistics. Use habits among adults of cigarettes, coffee, aspirin, and sleeping pills 1976 (Vital and Health Statistics series 10 no 131) DHEW publ no [PHS] 80-1559). Washinston: US Governmentt Printing Office; 1979:1-48.
4. Mahon J, Steel K, Feagan BG, et al. Use of acetylsalicylic acid by physicians and in the community. Can Med Assoc J 1991;145:1107-16.
5. Strom BL. Adverse reactions to over-the-counter analgesics taken for therapeutic purposes. JAMA 1994;272:1866-7.
6. Wilcox CM, Shalek KA, Cotsonis G. Striking prevalence of over-the-counter non-steroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage. Arch Inter Med 1994;154:42-6.
7. Gabriel ES, Fehring RA. Trends in the utilization of non-steroidal anti-inflammatory drugs in the United States, 1986-1990. J Clin Epidemiol 1992; 45(9):1041-4.
8. Chrischilles EA, Lemke JH, Wallace RB. Prevalence and characteristics of multiple analgesic drug use in an elderly study group. J Am Geriatr Soc 1990; 38:979-84.
9. Cheesbro JH, Fuster V, Elveback LR, et al. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol 1983;51:1537-41.
10. Dale J, Myhe E, Loew D. Bleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacement. Am Heart J 1980;99:746-51.
11. Turpie AGG, Gent M, Laupacis A, et al. Reduction in mortality by adding aspirin (100 mg) to oral anticoagulants in patients with heart valve replacement [abstract]. J Am Coll Cardiol 1992;19:103.
12. Meade TW, Roderick PJ, Brennan PJ, et al. Extracranial bleeding and other symptoms due to low-dose aspirin and low-intensity oral anticoagulation. Thromb Haemost 1992;68:1-6.
13. Cohen M, Adams PC, Parry G, et al. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Circulation 1994;89:81-8.
14. Goodman SG, Langer A. Duries SS, et al. Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Coumadin Aspirin Reinfarction (CARS) Pilot. Am J Cardiol 1994;74:656-7.
15. Hurlen M, Brikssen J, Smith P, et al. Comparison of bleeding complications of warfarin and warfarin plus acetylsalicylic acid: a study in 3166 outpatients. J Intern Med 1994;236:299-304.
16. Roth GJ, Calverley DC. Aspirin, platelets, and thrombosis: theory and practice. Blood 1994;83:885-98.
17. Kearon C, Hirsh J. Optimal dose for starting and maintaining low-dose aspirin. Arch Intern Med 1993;153:700-2.
18. Patrono C. Aspirin as an antiplatelet drug. Drug Therapy 1994;330:1287-94.
19. Brooks PM, Day RO. Non-steroidal anti-inflammatory drugs - differences and similarities. N Engl J Med 1991;324:1716-25.
20. Ali M, McDonald JWD. Reversible and irreversible inhibition of platelet cyclooxygenase and serotonin release by nonsteroidal and antiinflammatory drugs. Thromb Res 1978;13:1057-65.
21. Amadio P, Cummings DM, Amadio P. Non-steroidal anti-inflammatory drugs. Tailoring therapy to achieve results and avoid toxicity. Postgrad Med 1993;93:73-97.
22. Simon LS, Mills. JA. Non-steroidal anti-inflammatory drugs. N Engl J Med 1980;302:1237-43.
23. Kallis P. Tooze JA, Talbot S, et al. Pre-operative aspirin decreases platelet aggregation and increases post-operative blood loss - a prospective, randomized, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina. Eur J Cardiothorac Surg 1994;8:404-9.
24. Eauno P, Petersen KD, Husted SE. Increased blood loss after preoperarive NSAID. Retrospective study of 186 hip arthroplasties. Acta Orthop Scand 1993;64:522-4.
25. Robinson CM, Christie J, Malcolm-Smith N. Non-steroidal anti-inflammatory drugs, perioperative blood loss, and transfusion requirements in elective hip arthroplasty. J Arthroplasty 1993;8:607-10.
26. Kenny GNC. Potential renal, haematological and allergic adverse effects asssociated with nonsteroidal anti-inflammatory drugs. Drugs 1992;44:31-7.
27. Jacobus RBJ, Brouwers de Sinel P. Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs. Clin Pharmacokinet 1994;27:462-85.
28. Wells PS, Holbrook AM, Crowther NR, et al. Interactions of warfarin with drugs and food. Ann Intern Med 1994;121:676-83.
29. O'Callaghan JW, Thompson RN, Russell AS. Combining NSAIDs with anticoagulants: yes and no. Can Med Assoc J 1984;131:857-9.
30. Hilleman DE, Mohiuddin SM, Lucas BD Jr. Nonsteroidal antiinflammatory drug use in patients receiving warfarin: emphasis on nabumetone [review]. Am J Med 1993;95(2A):30S-34S.